99311: Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation among Cancer Survivors (1 credit)
Current Accrual: 81 out of 130 patients
Most Recent Documents (initial)
Protocol • Site Consent • WFU Consent* • Approval Letter
*The most recent WF consent is from them 2013 Continuing Review.
NicAlert kits will be sent to sites after registration. Please contact Sarah Hahne at shahne@wakehealth.edu with questions.